Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Nov 14;15(12):2095-2096.
doi: 10.1021/acsmedchemlett.4c00537. eCollection 2024 Dec 12.

Novel Aryl Hydrocarbon Receptor Agonists for Treating Psoriasis and Atopic Dermatitis

Ram W Sabnis  1
Affiliations
Editorial

Novel Aryl Hydrocarbon Receptor Agonists for Treating Psoriasis and Atopic Dermatitis

Ram W Sabnis. ACS Med Chem Lett. .

Abstract

Provided herein are novel aryl hydrocarbon receptor agonists, pharmaceutical compositions, use of such compounds in treating immune-mediated diseases, in particular psoriasis and atopic dermatitis, and processes for preparing such compounds.

PubMed Disclaimer

Conflict of interest statement

The author declares no competing financial interest.

References

    1. Yin X.; Yan Y.; Li J.; Cao Z.; Shen S.; Chang Q.; Zhao Y.; Wang X.; Wang P. Nuclear receptors for epidermal lipid barrier: Advances in mechanisms and applications. Exp. Dermatol. 2024, 33, e15107. 10.1111/exd.15107. - DOI - PubMed
    1. Bitterman D.; Kabakova M.; Wang J. Y.; Collins A.; Patel P.; Gupta N.; Zafar K.; Cohen M.; Jagdeo J. The role of aryl hydrocarbon receptor agonists in the treatment of vitiligo. Arch. Dermatol. Res. 2024, 316, 659. 10.1007/s00403-024-03405-2. - DOI - PubMed
    1. Lin X.; Meng X.; Lin J. The Role of Aryl Hydrocarbon Receptor in the Pathogenesis and Treatment of Psoriasis. J. Cutan. Med. Surg. 2024, 28, 276–286. 10.1177/12034754241239050. - DOI - PubMed
    1. Hawkes J. E.; Al-Saedy M.; Bouche N.; Al-Saedy S.; Drew D. T.; Song E. J. The Psoriasis Treatment Pipeline. Dermatol. Clin. 2024, 42, 365–375. 10.1016/j.det.2024.02.006. - DOI - PubMed
    1. Sabnis R. W. Novel AHR Agonists for Treating Psoriasis and Atopic Dermatitis. ACS Med. Chem. Lett. 2024, 15, 996–997. 10.1021/acsmedchemlett.4c00262. - DOI - PMC - PubMed

Publication types

LinkOut - more resources